Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study

BACKGROUND: Blood telomere length (BTL) is a validated biomarker of aging. ART reduces immunosenescence and has benefits in terms of BTL in people living with HIV (PLWH). However, it has also been observed that ART containing NRTIs, such as tenofovir or abacavir, which are potent inhibitors of human...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombardi, Francesca, Sanfilippo, Alessia, Fabbiani, Massimiliano, Borghetti, Alberto, Ciccullo, Arturo, Tamburrini, Enrica, Di Giambenedetto, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477130/
https://www.ncbi.nlm.nih.gov/pubmed/37534393
http://dx.doi.org/10.1093/jac/dkad237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477130/
https://www.ncbi.nlm.nih.gov/pubmed/37534393
http://dx.doi.org/10.1093/jac/dkad237

Ejemplares similares